CareMax, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the CareMax, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, CareMax, Inc. has published 31 public disclosures. The latest transaction was disclosed on 21 November 2023 (Levée d'options). Among the most active insiders: de Solo Carlos A.. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 November 2023
All Executives31 Thresholds0 Prospectus0 Other0
Declarations 31 total
◇ Director · Executives · 17 Nov 2023
12,123 shares Class A Common Stock SEC:0001209191-23-056293:0
◇ Director · Executives · 17 Nov 2023
12,123 shares Class A Common Stock SEC:0001193805-23-001524:0
◇ Director · Executives · 17 Nov 2023
10,927 shares Class A Common Stock SEC:0001209191-23-056294:0
◇ Director · Executives · 17 Nov 2023
12,123 shares Class A Common Stock SEC:0001193805-23-001525:0
◇ EVP, Treasurer and CFO · Executives · 8 Jun 2023
4,433 shares Class A Common Stock SEC:0001209191-23-036504:0
◇ EVP and COO · Executives · 8 Jun 2023
6,300 shares Class A Common Stock SEC:0001209191-23-036497:0
◇ President and CEO · Executives · 8 Jun 2023
14,300 shares Class A Common Stock SEC:0001209191-23-036498:0
◇ Director · Executives · 12 May 2023
23,381 shares Class A Common Stock SEC:0001209191-23-029980:0
◇ Director · Executives · 12 May 2023
16,187 shares Class A Common Stock SEC:0001209191-23-029974:0
◇ Director · Executives · 12 May 2023
18,585 shares Class A Common Stock SEC:0001209191-23-029982:0
◇ EVP and COO · Executives · 12 May 2023
15,108 shares Class A Common Stock SEC:0001209191-23-029976:0
◇ Director · Executives · 12 May 2023
16,187 shares Class A Common Stock SEC:0001209191-23-029972:0
◇ EVP, Treasurer and CFO · Executives · 12 May 2023
10,632 shares Class A Common Stock SEC:0001209191-23-029984:0
◇ President and CEO · Executives · 12 May 2023
34,293 shares Class A Common Stock SEC:0001209191-23-029978:0
◇ Director · Executives · 12 May 2023
16,187 shares 0Class A Common Stock SEC:0001209191-23-029970:0
▲ Director · Executives · 13 Mar 2023
10,000 shares @ US$3.46 0.4% of flow Class A Common Stock SEC:0001209191-23-018949:0
Canonical exit: 11 Jun 2023 (T+90) ◇ Director · Executives · 11 Nov 2022
15,500 shares Class A Common Stock SEC:0001209191-22-057156:0
● EVP, Treasurer and CFO · Executives · 14 Sept 2021
25,629 shares Class A Common Stock SEC:0001209191-22-057159:0
◇ Director · Executives · 11 Nov 2022
13,500 shares Class A Common Stock SEC:0001209191-22-057162:0
◇ Director · Executives · 11 Nov 2022
13,500 shares Class A Common Stock SEC:0001209191-22-057155:0
◇ Director · Executives · 11 Nov 2022
15,500 shares Class A Common Stock SEC:0001209191-22-057153:0
◇ Director · Executives · 11 Nov 2022
16,500 shares Class A Common Stock SEC:0001209191-22-057161:0
◇ EVP and COO · Executives · 11 Nov 2022
6,300 shares Class A Common Stock SEC:0001209191-22-057164:0
◇ President and CEO · Executives · 11 Nov 2022
14,300 shares Class A Common Stock SEC:0001209191-22-057154:0
● President and CEO · Executives · 7 Jul 2022
16,000 shares Class A Common Stock SEC:0001209191-22-041781:0
25 of 31 declarations
Load more (6 remaining) 关于 CareMax, Inc. CareMax, Inc. 是一家在美国纳斯达克上市的医疗保健公司,股票代码为 CMAX。对于从金融分析师角度评估该公司的法语投资者而言,该公司可被描述为一个技术驱动的、基于价值的护理平台,专注于 Medicare Advantage 患者和慢性病人群管理。CareMax 由 Carlos de Solo 和 Alberto de Solo 于 2011 年创立,最初在佛罗里达州建立了医疗中心网络,随后通过有机增长和收购相结合的方式进行扩张。其总部位于美国佛罗里达州迈阿密。
CareMax 商业模式的核心是临床护理交付、人口健康管理和专有技术的整合。该公司强调其 CareOptimize 平台,该平台旨在通过数据、分析和基于规则的工作流程支持医生,从而改善护理协调、预防性干预和患者监测。实际上,这使得 CareMax 不仅仅是一个传统的初级护理运营商:它旨在以符合基于价值的报销模式的方式,将面对面护理、社会服务和软件驱动的运营工具结合起来。
在运营方面,该公司已在美国多个州为患者提供服务。历史披露显示,其在佛罗里达州拥有显著业务,随后扩展到纽约、田纳西州和德克萨斯州。美国证券交易委员会(SEC)文件显示,截至 2024 年 6 月 30 日,CareMax 在 10 个州运营着 50 个中心并管理着附属医疗服务提供者。这一规模在全国范围内仍相对适中,但它为公司提供了多州的运营基础,并使其能够接触到广泛的以 Medicare 为导向的患者群体。该公司的护理模式以参加 Medicare Advantage 的老年人为中心,同时还提供更广泛的初级护理、慢性病管理和支持性社会服务。
从竞争角度来看,CareMax 在一个分散但竞争激烈的环境中运营,其中包括初级护理平台、管理式医疗提供者和其他基于价值的护理运营商。其差异化建立在垂直整合之上:实体护理场所、医生支持服务和专有技术层。理论上,如果执行得当,这种模式可以改善患者参与度和经济效益。实际上,该公司面临着巨大的财务压力。2024 年,管理层表示正在探索战略选择,以最大化某些资产的价值并改善流动性,同时缩减新中心投资并重新专注于核心中心的医疗利润和成本节约。2024 年末的披露还强调,其运营范围比前期有所缩小,拥有大约 46 个临床中心、约 1,100 名员工和约 260,000 名患者,这突显了公司正在经历重组和投资组合合理化时期。
对于投资者而言,关键在于 CareMax 仍然是一家在纳斯达克上市的美国医疗保健公司,在基于价值的护理方面拥有吸引人的战略概念,但其股票故事高度依赖于执行、融资灵活性以及管理层战略审查和重组工作的最终结果。